| |
ATC |
 1 Agents affecting nervous system and sensory organs
|
|
|
2 Agents affecting individual organs
|
|
|
 3 Agents affecting metabolism
|
31 Vitamins
|
32 Nutrients, tonics
|
33 Blood and body fluid agents
|
34 Dialysis agents
|
39 Other agents affecting metabolism
|
391 Liver disease agents
|
392 Antidotes
|
393 Habitual intoxication agents
|
394 Gout preparations
|
395 Enzyme preparations
|
396 Antidiabetic agents
|
3961 Sulfonylureas
|
3962 Biguanides
|
3969 Others
|
 D09744 Pioglitazone hydrochloride - metformin hydrochloride mixt
D09848 Pioglitazone hydrochloride - glimepiride mixt
D10159 Alogliptin benzoate - pioglitazone hydrochloride mixt
D00216 Acarbose (JAN/USAN/INN)
D00625 Miglitol (JAN/USAN/INN)
D01665 Voglibose (JP16/USAN/INN)
D00945 Pioglitazone hydrochloride (JP16/USP)
D06645 Sitagliptin phosphate hydrate (JAN); Sitagliptin phosphate (USAN)
D07080 Vildagliptin (JAN/USAN/INN)
D06553 Alogliptin benzoate (JAN/USAN)
D09566 Linagliptin (JAN/USAN/INN)
D00594 Repaglinide (JAN/USP/INN)
D01111 Nateglinide (JP16/USAN/INN)
D01854 Mitiglinide calcium hydrate (JAN)
D10160 Mitiglinide calcium hydrate - voglibose mixt
|
A10BD05
A10BD06
A10BD09
A10BF01
A10BF02
A10BF03
A10BG03
A10BH01
A10BH02
A10BH04
A10BH05
A10BX02
A10BX03
A10BX08
|
397 Metabolic disease preparations & combinations
|
399 Miscellaneous
|
|
|
4 Agents affecting cellular function
|
|
|
5 Crude drugs and Chinese medicine formulations
|
|
|
6 Agents against pathologic organisms and parasites
|
|
|
7 Agents not mainly for therapeutic purpose
|
|
|
8 Narcotics
|
Therapeutic Category of Drugs in Japan